A resilient net margin and a stock sitting near a two-year low. Those two facts should not coexist for a company that sells shampoo and dish soap to most of the world’s households. Yet here is Procter & Gamble in August 2026, earning more on every dollar of sales than it has in at least five years, while the market prices it as though something has quietly broken. Auditing that gap, rather than taking either side on faith, is the job of this piece.
P&G spent the early 2020s doing what consumer giants do in inflation: raise prices, watch volumes dip, and hope the math holds. For a while it did. Organic sales grew strongly in fiscal years 2022 and 2023, according to the July 29, 2026 earnings release. Then the consumer started pushing back. By fiscal year 2026, organic growth had slowed to a near-standstill. The stock, which once traded at a premium multiple befitting a near-monopoly on bathroom shelves, has drifted well below its 52-week high. The question the price is asking is whether the slowdown is a speed bump or a structural ceiling.
In one breath
The fiscal year 2026 10-K filing shows P&G earning $87 billion in revenue with a net margin of approximately 18%, our data show. The stock trades at a price-to-earnings multiple of 21, roughly at the low end of its own decade range, our data show. The price embeds a story of permanent deceleration. The filings, so far, do not confirm that story. Those two readings cannot both be right, and the distance between them is what this audit is about.
What the filings actually show
Start with the margin line, because it is the most surprising figure in the recent history. Fiscal year 2025 came with a net margin of 19%, up meaningfully from the year before. The full fiscal year 2026, just reported, held that improvement: $87 billion in revenue, net margin of approximately 18%, our data show. Think of it this way: for every $100 of Tide and Pantene sold, P&G is keeping $19 after every bill is paid. A few years ago, it kept noticeably less. The improvement is modest in absolute terms, but the direction matters, because the price assumes the direction has reversed.
Core earnings per share tell a similar story. The fiscal 2026 filing shows core EPS of $6.89, up slightly from fiscal 2025. That is not exciting growth. But it is growth, in a year when the company absorbed a meaningful decline in core operating margin, meaning costs rose faster than prices in the second half. The restructuring announced in June 2025, targeting up to 7,000 non-manufacturing jobs and promising $1.5 billion in annual savings, has not yet shown up fully in the numbers. That is a future variable the current price does not appear to credit.
Where the pessimism is embedded
A price-to-earnings multiple is simply the price tag per dollar of annual profit. A higher multiple means the market is willing to pay more for each dollar earned, usually because it expects those earnings to grow. P&G’s current multiple of 21, our data show, sits near the bottom of its own decade range, meaning the stock has been cheaper than this only rarely over ten years. That gap implies the market has priced in something close to stagnation, or worse.
The mood, to use our framework’s term for what the market is currently paying, assumes that organic growth stays near its recent floor, that margins face sustained pressure, and that P&G’s pricing power in premium categories is eroding for good. The math, what the filed fundamentals actually show, does not yet support that verdict. Nine of ten product categories grew or held organic sales in fiscal 2026, according to the July 29 earnings call transcript. All seven geographic regions did the same. That is not the fingerprint of a business in structural decline.
Piper Sandler, on August 4, 2026, cut its valuation estimate while maintaining a Neutral rating, citing macro uncertainty and elevated oil costs. The broader analyst consensus, per MarketBeat data, sits well above the current price, implying the sell side sees the current price as too pessimistic even after a cautious earnings report. BullScope takes no position on that gap, but it is worth noting that the consensus and the filing trend are pointing in the same direction, while the stock price is pointing the other way.
The real pressure points
The pessimism is not invented. The BNN Bloomberg report on the July 29 earnings call noted that lower-income consumers are trading down in grooming and oral care, seeking store-brand alternatives as food and energy costs squeeze household budgets. Core operating margin fell sharply in the fourth quarter alone, the third consecutive quarterly decline. P&G is also absorbing roughly $1 billion in after-tax cost headwinds in fiscal 2027 from energy, transportation, and materials, partly tied to the conflict in Iran, per the earnings call transcript.
The mix question matters here, and it is distinct from a simple growth question. P&G’s premium positioning, the reason Gillette razors cost multiples of the store brand, works as long as enough consumers stay in the premium tier. Beauty and wellness held up: volumes rose in the fourth quarter, and hair care and skin care grew for the full year, per the Investing.com earnings summary. Baby Care declined. The portfolio is not moving uniformly, and the acquisition of supplements maker Thorne, announced August 4, signals management is betting on health and wellness to carry more weight going forward.
Emerging-market pricing power is the variable the filings cannot fully illuminate yet. Currency headwinds are expected in fiscal 2027, per management guidance, a relatively modest number for a company this size. But the broader question, whether P&G can sustain premium pricing in markets where local competitors are gaining ground, remains open. The data do not answer it, and we will say so plainly.
The dividend as a floor signal
One figure that rarely gets its due in a growth conversation: P&G’s dividend yield has climbed to roughly 3% at today’s price, per DRIPInvesting data through August 5. The company returned over $15 billion to shareholders in fiscal 2026 through dividends and buybacks, and guided for similar returns in fiscal 2027. A business returning that much capital to shareholders is making a statement about confidence in cash generation. That statement is in the filing. The price, sitting near a two-year low, is making a different one. The gap between those two signals is the honest starting point for any analysis of whether the current price reflects the filed fundamentals.
Reading the numbers
- Net margin, ~18% in fiscal 2026 (10-K filed 2026): Net margin is what remains of each dollar of sales after every cost, tax, and interest payment. At roughly 18%, P&G keeps about $18 of every $100 in revenue. Think of a corner store that rings up $1,000 a day and pockets $190 after rent, wages, and stock. That margin is broadly in line with recent years, which makes the stock’s near-decade-low multiple harder to explain on fundamentals alone.
- P/E of 21, at the 7th percentile of the decade range, our data: The price-to-earnings multiple is the price tag per dollar of annual profit. At 21, the market is paying $21 for each dollar P&G earns. A household analogy: if a rental property earns $10,000 a year, a buyer paying $210,000 is applying a multiple of 21. P&G’s own median over ten years is 24, meaning the market has historically paid $240,000 for that same property. The current discount implies the market expects earnings to shrink or stall, which the filed trend does not yet show.
- Core EPS $6.89 in fiscal 2026, up 1% (10-K filed 2026): Core EPS strips out one-time restructuring charges to show the underlying earnings power. Up 1% is slow. But it is part of a multi-year growth trend in this figure, reaching $6.89 today. A savings account growing every year at a modest rate is not the same thing as one that has stopped growing.
- Organic sales growth of 1% in fiscal 2026 (earnings release, July 29): Organic growth measures sales change after stripping out currency swings and acquisitions, so it reflects real demand. At 1%, P&G is growing roughly as fast as inflation in a slow year. The concern is the trajectory: from robust growth a few years ago to near-stagnation in 2026. Whether that is a new floor or a trough is the question the next two quarters will start to answer.
Sources
- P&G 10-K, fiscal year ended June 30, 2026, SEC EDGAR
- P&G 10-Q, quarter ended March 31, 2026, SEC EDGAR
- P&G 10-K, fiscal year ended June 30, 2025, SEC EDGAR
- P&G 10-K, fiscal year ended June 30, 2024, SEC EDGAR
- P&G Q4 and Fiscal Year 2026 Earnings Release, July 29, 2026
- Earnings call transcript, Q4 fiscal 2026, Investing.com
- BNN Bloomberg, July 29, 2026
- Investing.com, fiscal 2026 earnings summary
- Investing.com, Thorne acquisition and fiscal 2027 outlook, August 4, 2026
- MarketBeat, P&G analyst consensus and dividend data
- DRIPInvesting, dividend yield data, August 5, 2026
- Human Resources Online, P&G restructuring announcement
